Burnout in ICU doctors and nurses in mainland China-A national cross-sectional study.

PURPOSE: A national cross-sectional study was performed to investigate the severity of burnout and its associated factors among doctors and nurses in ICUs in mainland China. METHOD: This is a cross-sectional survey. A total of 2411 ICU doctors and nurses in mainland China were included. Demographic and psychological data were collected via questionnaire. The Maslach Burnout Inventory (MBI) was used to evaluate burnout. Differences among regions and departments were analyzed. Multivariate logistic regression was applied to determine the associated factors. RESULTS: Among the participants, 1122 (46.54%) were doctors, and 1289 (53.46%) were nurses. A total of 800 doctors (71.3% of all doctors) and 881 nurses (68.3% of all nurses) were deemed to be burnout. People working in the general ICU were most likely to be burnout. Factors associated with burnout included having low frequency of exercise, having comorbidities, working in a high-quality hospital, having more years of work experience, having more night shifts and having fewer paid vacation days. CONCLUSIONS: The burnout rate of ICU doctors and nurses in mainland China is 69.7%. Our study provides baseline data about burnout among Chinese medical staff predating COVID-19, which could help in the analysis and interpretation of burnout during the COVID-19 pandemic.

Chinese Society of Interventional Radiology Expert Consensus on the prevention and control of COVID-19 in interventional radiology procedures (first edition).

The COVID-19 pandemic seriously threatens the lives of the general public and poses momentous challenges to all medical workers, including those engaged in interventional radiology, who play an important role in the diagnosis and treatment of various diseases. To further standardize the prevention and control of nosocomial infections and ensure the safety of doctors and patients, the Chinese Society of Interventional Radiology (CSIR) organized multidisciplinary experts in the field of interventional radiology in China to prepare an "Expert Consensus" elaborating and summarizing the protective strategies and suggestions for medical workers in the field of interventional radiology when they engage in interventional diagnosis and treatment activities against the background of novel coronavirus infection control. The aim is to provide a reference for interventional procedures in hospitals and other medical institutions at all levels in China and worldwide. The key points include the following: (I) non-emergency interventional diagnosis and treatment should be suspended while work is ongoing to prevent and control the spread of COVID-19; (II) protective measures should be taken according to the appropriate level designated for COVID-19 infection prevention and control; (III) patients should take measures to protect themselves when they want to see a doctor, including accessing outpatient services online and other relevant channels of consultation.

CSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic.

The coronavirus disease 2019 (COVID-19) has become a global pandemic since its outbreak in December 2019, which posed a threat to the safety and well-being of people on a global scale. Cancer patients are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and their critical morbidity and case fatality rates are high. The ablation expert committee of the Chinese Society of Clinical Oncology compiled corresponding expert recommendations. These recommendations summarize the preventive measures and management of tumor ablation treatment in medical institutions, including outpatient clinics, oncology wards, ablation operation room, and postablation follow-ups in accordance with the guidelines and protocols imposed by the National Health Commission of the People's Republic of China and the experience in management and prevention according to various hospitals. This consensus aims to reduce and prevent the spread of SARS-CoV-2 and its cross-infection between cancer patients in hospitals and provide regulatory advice and guidelines for medical personnel.